CELLUJUVE
Live / Registered — Registered (as of 31 Oct 2023)
What this means for you
Registered since 31 Oct 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 31 Oct 2029: the §8 declaration of use).
Record
- Serial number
- 90377657
- Registration number
- 7204278
- Mark type
- Word mark
- Filed
- 12 Dec 2020
- Published for opposition
- 15 Aug 2023
- Registered
- 31 Oct 2023
- Next maintenance filing
- §8 declaration of use, due by 31 Oct 2029 (grace period to 30 Apr 2030)
- Attorney of record
- R. Scott Keller
Goods and services
- Class 005 — Pharmaceuticals: Injectable dermal filler consisting of biological materials; injectable dermal filler consisting of artificial materials
Owner
- SPIDERWORT BIOTECHNOLOGIES INC., OTTAWA, CA
- Spiderwort Inc., Ottawa, Ontario, CA
- Spiderwort Inc., Ottawa, Ontario, CA
- Spiderwort Inc., Ottawa, Ontario, CA
Prosecution history
- 24 Feb 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 31 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 15 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Aug 2023 — PUBLISHED FOR OPPOSITION
- 26 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jul 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Jul 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 May 2023 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 20 May 2023 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 19 May 2023 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 19 May 2023 — LETTER OF SUSPENSION E-MAILED
- 19 May 2023 — SUSPENSION LETTER WRITTEN
- 19 May 2023 — USE AMENDMENT ACCEPTED